Medicine Safety During Pregnancy: Complete Category Guide

Medications During Pregnancy: Balancing Risk and Benefit

Nearly 90% of pregnant women take at least one medication during pregnancy, and over 70% take a prescription medicine. The challenge is that most medicines have limited safety data in pregnancy — clinical trials routinely exclude pregnant women. Healthcare providers and patients must make decisions based on available observational data, animal studies, case reports, and pregnancy registries.

---

The Old FDA Letter Categories (A, B, C, D, X)

For decades, the FDA used a letter system to categorize medicine risk in pregnancy:

Category A: Adequate controlled studies show no fetal risk in the first trimester (and no evidence in later trimesters). Examples: folic acid, levothyroxine at replacement doses.

Category B: Either animal studies show no fetal risk but there are no adequate human studies, OR animal studies show adverse effect but adequate human studies fail to show risk. Examples: acetaminophen, amoxicillin, metformin.

Category C: Animal studies have shown adverse effects on the fetus, but no adequate human studies are available, OR no animal or human studies have been conducted. Use if potential benefit justifies risk. Examples: sertraline, fluconazole (single dose), many antiemetics.

Category D: Positive evidence of human fetal risk, but benefits may outweigh risks in serious conditions. Examples: phenytoin, lithium, tetracyclines (after 1st trimester).

Category X: Studies in animals or humans have demonstrated fetal abnormalities. Risk outweighs any benefit. Contraindicated in pregnancy. Examples: isotretinoin (Accutane), thalidomide, warfarin (1st trimester), methotrexate, finasteride.

---

The New PLLR System (Since 2015)

The FDA replaced letter categories with the Pregnancy and Lactation Labeling Rule (PLLR) for medicines approved after June 30, 2015. The new label contains narrative descriptions instead of a letter grade, covering three sections:

8.1 Pregnancy: Clinical considerations, dosing adjustments, maternal and fetal/neonatal adverse reactions, and data summary (human and animal). Includes a pregnancy exposure registry contact if one exists.

8.2 Lactation: Whether the medicine is present in human milk, effects on the breastfed infant, and effects on milk production.

8.3 Females and Males of Reproductive Potential: Pregnancy testing, contraception requirements, and infertility considerations.

---

Specific Medicine Safety Guidance

#

Safe During Most of Pregnancy

Acetaminophen: Long considered safe for pain and fever. Recent evidence suggests possible association with ADHD/autism at high doses, but occasional use remains acceptable.

Penicillins, cephalosporins: First-line antibiotics for most bacterial infections in pregnancy.

Prenatal vitamins: Folic acid (400–800 mcg) critical for neural tube defect prevention; started before conception.

Insulin: Preferred for diabetes management in pregnancy; does not cross placenta.

#

Use With Caution — Benefit vs. Risk

SSRIs/SNRIs: Risk of neonatal adaptation syndrome with late pregnancy use (jitteriness, respiratory distress — typically transient). Untreated depression carries significant risks too.

Metformin: Increasingly used for gestational diabetes; crosses placenta but no clear teratogenic signal.

Proton pump inhibitors: Generally considered safe; some concerns from animal data.

#

Avoid or Contraindicated

ACE inhibitors / ARBs: Category D in 2nd/3rd trimester — cause fetal renal dysgenesis, oligohydramnios, and neonatal renal failure. Switch to methyldopa or labetalol for hypertension.

NSAIDs (ibuprofen, naproxen): Avoid after 20 weeks — risk of premature closure of ductus arteriosus and oligohydramnios (new FDA warning, 2020).

Isotretinoin (Accutane): Causes severe birth defects in virtually every exposed pregnancy. iPLEDGE REMS program requires monthly negative pregnancy tests.

Warfarin: Warfarin embryopathy in 1st trimester; fetal hemorrhage. Use LMWH heparin instead.

Tetracyclines: Permanent tooth staining and enamel hypoplasia if used after 1st trimester.

Valproate (Depakote): Highest teratogenic risk of any antiepileptic — neural tube defects, cognitive impairment.

Thalidomide/lenalidomide: Absolute contraindication; requires REMS.

---

Breastfeeding Safety

Most medications pass into breast milk to some extent, but most are present at doses far too low to cause harm. Key considerations:

Timing doses after feeding and before the infant's longest sleep period reduces exposure.

LactMed (NCBI database) is the gold standard reference for lactation medicine safety.

Medicines to avoid while breastfeeding include: lithium, amiodarone, chemotherapy, radiopharmaceuticals.

Most antibiotics, SSRIs, and antihypertensives are compatible with breastfeeding with appropriate monitoring.